Detail akcie INNO-GENE online

Business Summary: Inno-Gene SA is a Poland-based holding company engaged in management of a portfolio of companies active in life-science sector through the technology, research and development. Inno-Gene SA’s portfolio comprises of Centrum Badan DNA Sp. z o.o., a company that provides services in the field of genetic medical diagnostics, including microbiological diagnosis of infection and the suitability of human congenital diseases using tests performed on DNA microarray technology. On March 22, 2013, the Company established a new subsidiary, Centrum Edukacji Bio-Medycznej Sp. z o.o. On April 11, 2013, the Company established two new indirect subsidiaries, Genomix Sp. z o.o. and Madgenetix Sp. z o.o. In addition, it operates through VitainSillica Sp z o o.
Financial Summary: BRIEF: For the six months ended 30 June 2023, Inno-Gene SA revenues decreased 94% to PLN910K. Net loss totaled PLN649K vs. income of PLN2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net loss reflects Other Operating Income decrease of 63% to PLN113K (income), Subsidies decrease from PLN155K (income) to PLN0K.